189 related articles for article (PubMed ID: 33252330)
1. Evolved bacterial resistance against fluoropyrimidines can lower chemotherapy impact in the
Rosener B; Sayin S; Oluoch PO; García González AP; Mori H; Walhout AJ; Mitchell A
Elife; 2020 Nov; 9():. PubMed ID: 33252330
[TBL] [Abstract][Full Text] [Related]
2. Evolved bacterial resistance to the chemotherapy gemcitabine modulates its efficacy in co-cultured cancer cells.
Sayin S; Rosener B; Li CG; Ho B; Ponomarova O; Ward DV; Walhout AJM; Mitchell A
Elife; 2023 Feb; 12():. PubMed ID: 36734518
[TBL] [Abstract][Full Text] [Related]
3. Dietary serine-microbiota interaction enhances chemotherapeutic toxicity without altering drug conversion.
Ke W; Saba JA; Yao CH; Hilzendeger MA; Drangowska-Way A; Joshi C; Mony VK; Benjamin SB; Zhang S; Locasale J; Patti GJ; Lewis N; O'Rourke EJ
Nat Commun; 2020 May; 11(1):2587. PubMed ID: 32444616
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of pyrimidine biosynthesis enzymes using the anticancer drug 5-fluorouracil in Caenorhabditis elegans.
Kim S; Park DH; Kim TH; Hwang M; Shim J
FEBS J; 2009 Sep; 276(17):4715-26. PubMed ID: 19645718
[TBL] [Abstract][Full Text] [Related]
5. Bacterial Metabolism Affects the C. elegans Response to Cancer Chemotherapeutics.
García-González AP; Ritter AD; Shrestha S; Andersen EC; Yilmaz LS; Walhout AJM
Cell; 2017 Apr; 169(3):431-441.e8. PubMed ID: 28431244
[TBL] [Abstract][Full Text] [Related]
6. Some pyrimidines of biological and medicinal interest. I.
Cheng CC
Prog Med Chem; 1969; 6():67-134. PubMed ID: 4182779
[No Abstract] [Full Text] [Related]
7. Temporal Transcriptomics of Gut Escherichia coli in Caenorhabditis elegans Models of Aging.
Brycki JD; Chen See JR; Letson GR; Emlet CS; Unverdorben LV; Heibeck NS; Brislawn CJ; Buonaccorsi VP; Chan JP; Lamendella R
Microbiol Spectr; 2021 Oct; 9(2):e0049821. PubMed ID: 34523995
[TBL] [Abstract][Full Text] [Related]
8. Host-Microbe Co-metabolism Dictates Cancer Drug Efficacy in C. elegans.
Scott TA; Quintaneiro LM; Norvaisas P; Lui PP; Wilson MP; Leung KY; Herrera-Dominguez L; Sudiwala S; Pessia A; Clayton PT; Bryson K; Velagapudi V; Mills PB; Typas A; Greene NDE; Cabreiro F
Cell; 2017 Apr; 169(3):442-456.e18. PubMed ID: 28431245
[TBL] [Abstract][Full Text] [Related]
9. Strength of Cu-efflux response in Escherichia coli coordinates metal resistance in Caenorhabditis elegans and contributes to the severity of environmental toxicity.
Shafer CM; Tseng A; Allard P; McEvoy MM
J Biol Chem; 2021 Sep; 297(3):101060. PubMed ID: 34375643
[TBL] [Abstract][Full Text] [Related]
10. Age-dependent effects of floxuridine (FUdR) on senescent pathology and mortality in the nematode Caenorhabditis elegans.
Wang H; Zhao Y; Zhang Z
Biochem Biophys Res Commun; 2019 Feb; 509(3):694-699. PubMed ID: 30611569
[TBL] [Abstract][Full Text] [Related]
11. Quantifying the Determinants of Evolutionary Dynamics Leading to Drug Resistance.
Chevereau G; Dravecká M; Batur T; Guvenek A; Ayhan DH; Toprak E; Bollenbach T
PLoS Biol; 2015; 13(11):e1002299. PubMed ID: 26581035
[TBL] [Abstract][Full Text] [Related]
12. In the Model Host
Lee K; Escobar I; Jang Y; Kim W; Ausubel FM; Mylonakis E
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33105563
[TBL] [Abstract][Full Text] [Related]
13. Effect of fluoropyrimidines on the growth of Ureaplasma urealyticum.
Wehelie R; Eriksson S; Wang L
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1499-502. PubMed ID: 15571285
[TBL] [Abstract][Full Text] [Related]
14. Fluorodeoxyuridine affects the identification of metabolic responses to daf-2 status in Caenorhabditis elegans.
Davies SK; Leroi AM; Bundy JG
Mech Ageing Dev; 2012 Jan; 133(1):46-9. PubMed ID: 22116032
[TBL] [Abstract][Full Text] [Related]
15. Novel Immune Modulators Enhance
Hummell NA; Revtovich AV; Kirienko NV
mSphere; 2021 Jan; 6(1):. PubMed ID: 33408224
[TBL] [Abstract][Full Text] [Related]
16. Isolation of fluoropyrimidine-resistant murine leukemic cell lines by one-step mutation and selection.
Mulkins MA; Heidelberger C
Cancer Res; 1982 Mar; 42(3):956-64. PubMed ID: 6460554
[TBL] [Abstract][Full Text] [Related]
17. The symbiotic relationship between Caenorhabditis elegans and members of its microbiome contributes to worm fitness and lifespan extension.
Haçariz O; Viau C; Karimian F; Xia J
BMC Genomics; 2021 May; 22(1):364. PubMed ID: 34011272
[TBL] [Abstract][Full Text] [Related]
18. Determinants of sensitivity and resistance to fluoropyrimidines.
Aschele C; Guglielmi A; Maioli D; Sobrero A; Rosso R; Nicolin A
Pharmacol Res; 1990; 22 Suppl 3():1-2. PubMed ID: 2151469
[No Abstract] [Full Text] [Related]
19. Acceleration and suppression of resistance development by antibiotic combinations.
Suzuki S; Horinouchi T; Furusawa C
BMC Genomics; 2017 Apr; 18(1):328. PubMed ID: 28446153
[TBL] [Abstract][Full Text] [Related]
20. Enhanced protection of pathogenic Escherichia coli ingested by a soil nematode Caenorhabditis elegans against sanitizer treatments.
Park MR; Oh S; Yun HS; Kim SH; Ko YH; Ryu JH; Rhee MS; Shin OS; Kim Y
Biosci Biotechnol Biochem; 2014; 78(11):1917-22. PubMed ID: 25052260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
